Why Nucor Shares Are Trading Lower? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of Nucor Corporation NUE fell sharply during Tuesday's session after the company reported worse-than-expected quarterly financial results.
Nucor reported quarterly earnings of $3.46 per share which missed the analyst consensus estimate of $3.65. Quarterly sales came in at $8.14 billion, missing the analyst consensus estimate of $8.26 billion, according to data from Benzinga Pro.
Nucor shares tumbled 6.5% to $179.20 on Tuesday.
Here are some other stocks moving in today’s mid-day session.
Gainers
- Cyngn Inc. CYN shares jumped 100% to $0.2419 after the company announced that it has been chosen to supply its DriveMod Tuggers for industrial automation to John Deere’s operation in Dubuque, Iowa.
- Pineapple Energy Inc. PEGY shares climbed 50.4% to $0.0689 after falling 10% on Monday.
- Oportun Financial Corporation OPRT gained 46% to $3.29 after the company announced preliminary first-quarter total revenue above estimates.
- Palisade Bio, Inc. PALI shares climbed 44.3% to $7.12 after the company entered a collaboration with Strand Life Sciences.
- KULR Technology Group, Inc. KULR gained 27% to $0.5683 after the company announced it delivered on an immediate basis, a power cell battery deployment order for AI-enabled drone and advanced air mobility missions in Ukraine.
- Smart for Life, Inc. SSMFL climbed 20% to $5.22.
- HWH International Inc. HWH rose 19.5% to $1.5307 after declining 3% on Monday.
- SolarMax Technology, Inc. SMXT gained 18.7% to $9.49.
- Hibbett, Inc. HIBB rose 18.4% to $85.85 after the company agreed to be acquired by JD Sports Fashion for $87.50 per share in cash, in a $1.1 billion transaction.
- SES AI Corporation SES gained 17.4% to $1.3499.
- SolarMax Technology, Inc. SMXT rose 15.5% to $9.24.
- FuelCell Energy, Inc. FCEL gained 15.5% to $0.9295.
- Carmell Corporation CTCX climbed 15.2% to $2.20.
- Azitra, Inc. AZTR shares gained 15% to $0.2244 after the company announced new preclinical data will be presented at the American Society of Gene and Cell Therapy meeting.
- Virgin Galactic Holdings, Inc. SPCE jumped 14.4% to $0.8603.
- 9F Inc. JFU rose 14.3% to $3.29.
- Canaan Inc. CAN gained 14% to $1.05. The company executives announced intentions to purchase at least $2 million of the company's common stock.
- Cartesian Therapeutics, Inc. RNAC jumped 12.7% to $20.59 after Leerink Partners initiated coverage on the stock with an Outperform rating and announced a $39 price target.
- Spotify Technology S.A. SPOT gained 12.3% to $305.73 following first-quarter financial results.
- Heron Therapeutics, Inc. HRTX climbed 11.6% to $2.89 after Capital One initiated coverage on the stock with an Overweight rating and $6 price target.
- Mesoblast Limited MESO gained 9.4% to $6.05.
- Ryder System, Inc. R rose 9% to $118.82 following better-than-expected quarterly earnings.
- Bloom Energy Corporation BE jumped 8.8% to $10.15.
- HealthStream, Inc. HSTM surged 7.4% to $25.91 following upbeat quarterly results.
- Cidara Therapeutics, Inc. CDTX shares rose 7% to $0.55 following upbeat quarterly results.
- Roku, Inc. ROKU gained 6.2% to $62.20.
Losers
- Abeona Therapeutics Inc. ABEO fell 48.4% to $3.7950 after the company announced the FDA issued a Complete Response Letter in response to the company’s Biologics License Application for pz-cel for the treatment of patients with recessive dystrophic epidermolysis bullosa.
- Greenwave Technology Solutions, Inc. GWAV shares fell 44.6% to $0.0699. Greenwave Technology Solutions disclosed that it further strengthened its balance sheet by approximately $12 million.
- Lichen China Limited LICN fell 44.4% to $0.5450.
- Tungray Technologies Inc. TTRSG shares declined 34.2% to $4.87 after gaining 24% on Monday.
- Tian Ruixiang Holdings Ltd TTIRX fell 26.3% to $0.5091.
- Moolec Science SA MLEC fell 24.3% to $1.87. On April 22, Moolec Science said it received approval for its plant-grown animal proteins.
- YY Group Holding Limited YYYGH fell 22.4% to $2.25 after tumbling over 27% on Monday. The company, last week, priced its IPO at $4 per share.
- Top Wealth Group Holding Limited TTWG dipped 19.7% to $2.0899.
- Comstock Holding Companies, Inc. CHCI declined 18.8% to $6.44.
- SuperCom Ltd. SPCB dipped 18% to $0.2369. SuperCom recently reported better-than-expected quarterly results.
- JetBlue Airways Corporation JBLU declined 16.2% to $6.29 after the company reported first-quarter financial results and issued worse-than-expected Q2 and FY24 Revenue outlook.
- MSCI Inc. MSCI declined 13% to $448.01 following first-quarter financial results.
- LKQ Corporation LKQ fell 12.6% to $42.78 after the company reported a first-quarter earnings miss and cut its FY24 outlook.
- Simpson Manufacturing Co., Inc. SSD dipped 11.7% to $163.40 following weak quarterly earnings.
- Jaguar Health, Inc. JAGX shares fell 11.2% to $0.1598 after the company filed for a mixed shelf offering of up to $75 million.
- Xerox Holdings Corporation XRX tumbled 11.1% to $14.60 after the company reported worse-than-expected first-quarter results and reiterated FY24 guidance.
- T2 Biosystems, Inc. TTOO declined 10.4% to $2.83 after gaining around 7% on Monday.
- Sasol Limited SSL shares fell 10.1% to $7.13 after the company issued its production and sales performance metrics for the nine months ended 31 March, 2024.
- Complete Solaria, Inc. CSLR fell 9.3% to $0.3530 after dipping around 14% on Monday.
- Cleveland-Cliffs Inc. CLF dipped 7.8% to $19.22 after the company’s reported worse-than-expected first-quarter financial results.
- Phio Pharmaceuticals Corp. PHIO fell 7.1% to $0.77. Phio Pharmaceuticals shares jumped around 33% on Monday after the company announced that its intratumoral injection of murine PH-762 inhibited tumor growth in murine tumor models and may generate memory-specific T cells.
- Calix, Inc. CALX shares fell 4.1% to $28.34 after the company reported mixed first-quarter financial results and issued second-quarter guidance below estimates.
Read More: Bitcoin Surpasses $66,000; Akash Network, Core Among Top Gainers
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.